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Kalata B1 is a prototypic member of the unique cy-
clotide family of macrocyclic polypeptides in which the
major structural features are a circular peptide back-
bone, a triple-stranded b-sheet, and a cystine knot ar-
rangement of three disulfide bonds. The cyclotides are
the only naturally occurring family of circular proteins
and have prompted us to explore the concept of acyclic
permutation, i.e. opening the backbone of a cross-linked
circular protein in topologically permuted ways. We
have synthesized the complete suite of acyclic permu-
tants of kalata B1 and examined the effect of acyclic
permutation on structure and activity. Only two of six
topologically distinct backbone loops are critical for
folding into the native conformation, and these involve
disruption of the embedded ring in the cystine knot.
Surprisingly, it is possible to disrupt regions of the
b-sheet and still allow folding into native-like structure,
provided the cystine knot is intact. Kalata B1 has mild
hemolytic activity, but despite the overall structure of
the native peptide being retained in all but two cases,
none of the acyclic permutants displayed hemolytic ac-
tivity. This loss of activity is not localized to one partic-
ular region and suggests that cyclization is critical for
hemolytic activity.
Circular permutation is a conceptually intriguing tool that
has been applied in recent years for the study of protein folding.
It involves the synthesis or expression of proteins in which the
position of the N and C termini are permuted from their native
locality. It may be thought of as joining the ends of a protein
and then opening the chain elsewhere. These experiments have
shown that it is possible in some cases to permute the termini
of a protein and still allow folding into the native conformation
(1, 2), thus providing valuable information on protein folding.
In practice the conceptual “circular proteins” intrinsic to the
design of circular permutants are never actually synthesized
but are theoretical intermediates. The recent discovery of a
naturally occurring family of circular proteins, however, allows
us to start from a circular protein and explore the concept of
“acyclic permutation.” In the current study we introduce this
concept for the prototypic circular protein, kalata B1, the first
circular protein to be structurally characterized.
Kalata B1 belongs to a family of macrocyclic peptides termed
the cyclotides (3) that are approximately 30 amino acids in
length with three disulfide bonds and are isolated from plants
in the Rubiaceae and Violaceae families (4–7). These peptides
display an interesting range of biological activities, which led to
their initial discovery. The circulins were found in a screen for
anti-human immunodeficiency virus activity (8), cyclopsycho-
tride A inhibits neurotensin binding to cell membranes (9), and
kalata B1 shows uterotonic activity (6, 10). Violapeptide I (11)
was originally discovered based on its hemolytic activity, and it
has recently been shown that kalata B1 (12, 13), the circulins
(12, 13), and cyclopsychotride A (13) also have relatively weak
hemolytic activity. A large number of additional peptides from
this family have recently been discovered. The varv peptides
A-H have been isolated from Viola arvensis (14, 15), and we
have reported the discovery of several peptides from Viola
odorata, Viola hederaceae, and Oldenlandia affinis (3). There is
approximately 40% sequence conservation throughout the
known sequences. The importance of this family of unusually
large cyclic peptides has been increased by the discovery of
their anti-microbial activity against various strains of bacteria
and fungi (13).
The three-dimensional structures of three members of this
family (kalata B1 (10), circulin A (16), and cycloviolacin O1 (3))
have been determined by NMR spectroscopy and reveal the
presence of a cyclic cystine knot motif, so named because of the
N- to C-cyclized backbone and knotted three-dimensional
structure (3, 12). The disulfide bonds are in a cystine-knot
arrangement with the Cys connectivities I-IV, II-V, and III-VI
(10, 17) in which two disulfide bonds and their connecting
backbone segments produce an eight-residue cycle through
which the third disulfide bond “threads” (10). The threading of
this embedded eight-residue cycle is highlighted in Fig. 1. The
cyclic cystine knot motif is distinct because of its cyclic back-
bone; however, the cystine knot motif is present in a large
number of peptides and proteins with diverse functions. These
include ion channel toxins (18), proteinase inhibitors (18), and
growth factors (19), and it has recently been suggested that a
phenoloxidase inhibitor is also a member of this family (20). It
is therefore of great interest to explore the folding of this
important motif.
Numerous other peptide families contain characteristic cys-
tine frameworks (i.e. the positions and spacings between the
cysteine residues) that appear to stabilize structural motifs
(21), and thus, it is interesting to examine the effect of chang-
ing the cystine framework on folding and structure. Permuting
the termini of acyclic derivatives of kalata B1 effectively alters
the cystine framework, and thus, this study has broader impli-
cations than just for cystine knot peptides.
We have previously reported the synthesis and folding of
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kalata B1 using two separate strategies (12), one in which the
disulfide bonds were formed before cyclization, and the other in
which cyclization preceded oxidation of the cysteine residues.
These two strategies allowed a comparison of the folding of
kalata B1 in the linear and cyclic forms. Cyclization appeared
to have a dramatic effect on folding, as oxidation of cyclic-
reduced kalata B1 produced the correctly folded peptide in
aqueous solution, in contrast to the case for the linear form
where oxidation in water produced mainly misfolded products.
However, a significant proportion of correctly folded peptide
was obtained from the linear precursor when oxidation reac-
tions were performed in the presence of organic solvents. A
hydrophobic solution environment appeared to be required to
stabilize the surface-exposed hydrophobic residues that are
formed upon folding into the native conformation (12). Further-
more, hemolytic activity was observed for cyclized kalata B1
but not for the oxidized linear derivative (12). These results
implied that cyclization was either very important for activity
or that the particular backbone segment that was opened in the
linear derivative was important for maintaining activity. It
was evident that further linear analogues were required to
resolve this question. In the current study we have synthesized
the complete suite of topologically distinct acyclic permutants
of kalata B1. The effects of acyclic permutation on folding,
structure, and activity are examined.
EXPERIMENTAL PROCEDURES
Synthesis of Acyclic Permutants of Kalata B1—Permutants of kalata
B1 were assembled using manual solid phase peptide synthesis with
tert-butoxycarbonyl chemistry on a 0.5-mmol scale. p-Methylbenzhy-
drylamine or 4-(oxymethyl)phenylacetamidomethyl resin was used (Ap-
plied Biosystems, Foster City, CA), and amino acids were added to the
resin using 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium with
in situ neutralization (22). Cleavage of the peptide from the resin was
achieved using hydrogen fluoride (HF) with cresol and thiocresol as
scavengers (HF:cresol:thiocresol; 9:1:1 v/v). The reaction was allowed to
proceed at 25–0 °C for 1 h. After cleavage, the peptides were dissolved
in 50% acetonitrile, 0.1% trifluoroacetic acid and lyophilized. The crude,
reduced peptides were purified using preparative reverse-phase HPLC
(RP-HPLC)1 on a Vydac C18 column. Gradients of 0.1% aqueous triflu-
oroacetic acid and 90% acetonitrile, 0.09% trifluoroacetic acid were
employed with a flow rate of 8 ml/min, and the eluant was monitored at
230 nm. These conditions were used in the subsequent purification
steps. Mass analysis was performed on a Sciex (Thornhill, Ontario)
triple quadrupole mass spectrometer using electrospray sample
ionization.
Disulfide Formation—Oxidation reactions were performed using the
best conditions established for the cyclic peptide (12). The purified
reduced peptides were dissolved in 50% 2-propanol, 1–10 mM reduced
glutathione in 0.1 M ammonium bicarbonate (pH 8.5). The reactions
were left at room temperature for 24 h. The pH was lowered with
trifluoroacetic acid before purification with RP-HPLC.
NMR Spectroscopy—Samples for 1H NMR measurements contained
1 mM peptide in either 99.99% 2H2O or 90% H2O, 10%
2H2O (v/v) at
;pH 4. 2H2O (99.9% and 99.99%) was obtained from Cambridge Isotope
Laboratories, Woburn, MA. Spectra were recorded at 12 °C and 25 °C
on a Bruker ARX-500 spectrometer equipped with a shielded gradient
unit. Low temperature studies employed a temperature-controlled
stream of cooled air using a Bruker BCU refrigeration unit and a B-VT
2000 control unit. Two-dimensional NMR spectra were recorded in
phase-sensitive mode using time-proportional phase incrementation for
quadrature detection in the t1 dimension (23). The two-dimensional
experiments included DQF-COSY (24), TOCSY (25) using a MLEV-17
spin lock sequence (26) with a mixing time of 80 ms, and NOESY (27)
with mixing times of 200 ms and 250 ms. For DQF-COSY experiments,
solvent suppression was achieved using selective low power irradiation
of the water resonance during a relaxation delay of 1.8 s. Solvent
suppression for NOESY and TOCSY experiments was achieved using a
modified WATERGATE (water suppression by gradient-tailored excita-
tion) sequence (28). Spectra were routinely acquired over 6024 Hz with
4096 complex data points in F2 and 512 increments in the F1 dimension.
Slowly exchanging NH protons were detected by acquiring a series of
one-dimensional and TOCSY spectra of the fully protonated peptide
immediately after dissolution in 2H2O. Exchange rates for amide pro-
tons were determined using these spectra, with the volumes measured
using XWINNMR and normalized to a non-exchangeable proton. The
exchange rates were calculated by fitting the volume of the decaying
signals over time to the equation I 5 Io exp(2kex 3 t) 1 I (‘) (29).
3JaHNH coupling constants were measured either from one-dimensional
spectra or from DQF-COSY spectra transformed to 8192 3 1024 over
the region of interest.
Spectra were processed on a Silicon Graphics Indigo workstation
using XWINNMR (Bruker) software. The t1 dimension was zero-filled to
2048 real data points, and 90° phase-shifted sine bell window functions
were applied before Fourier transformation. Chemical shifts were ref-
erenced to DSS at 0.00 ppm.
Hemolytic Activity Assay—Human erythrocytes (blood group O) were
washed several times with phosphate-buffered saline and centrifuged
at 3500 rpm until a clear supernatant was obtained. A 1% solution of
the red blood cells in phosphate-buffered saline was used in the assays,
which were performed by adding 20 ml of test compound to 80 ml of the
1% suspension of red blood cells. A 1% solution of SDS was used as a
control for 100% hemolysis (30). The mixtures were left at room tem-
perature for 1 h and then centrifuged at 3500 rpm for 1 min. The
supernatant (20 ml) was diluted with 580 ml of deionized (Milli-Q)
water, and the absorbance was measured at 415 nm.
RESULTS
There are six cysteine residues in peptides from the cyclotide
family and, hence, six loops in the backbone that can be opened
to form six topologically distinct acyclic permutants. We have
synthesized a series of truncated acyclic permutants of kalata
B1 in which each of the six loops has been opened to examine
the effects of acyclic permutation on folding, structure, and
activity. A schematic representation of the acyclic permutants
is shown in Fig. 2. In general the permutants were designed to
include one residue adjacent to each of the two cysteine resi-
dues spanning the cut site, with any intervening residues de-
1 The abbreviations used are: RP-HPLC, reversed-phase high per-
formance liquid chromatography; TOCSY, two-dimensional total corre-
lation spectroscopy; NOE, nuclear Overhauser effect; NOESY,
two-dimensional NOE spectroscopy; DQF-COSY, double quantum
filtered correlation spectroscopy; DSS, sodium 2,2-dimethyl-2-
silapentane-5-sulfonate.
FIG. 1. The sequence and three-dimensional structure of
kalata B1. The eight-residue loop formed by the disulfide bonds I-IV
and II-V is highlighted in blue with the rest of the backbone shown in
pink, and the cysteine side chains shown in yellow.
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leted. However, in some cases only a single residue was deleted
or the permutants contain the entire amino acid sequence of
kalata B1 but are acyclic. The sequences and nomenclature of
the seven permutants synthesized are shown in Table I. Since
the parent protein is cyclic, the choice of the numbering system
for amino acid residues is arbitrary, but we have followed that
introduced earlier by Daly et al. (16). However, since our focus
here is on the concept of acyclic permutation, it is also conven-
ient to refer to individual peptides via the backbone loop that is
removed, (1–6), as summarized in Table I and Fig. 2. Single
permutants were made for loops 1–5, and two acyclic permu-
tants were made for loop 6: 6a, which corresponds to complete
removal of the loop, and 6b, in which the loop is cut but no
residues are removed.
All permutants, with the exception of kalata B1(8–7), i.e. 2,
were synthesized on p-methylbenzhydrylamine resin to pro-
duce a C-terminal amide upon cleavage with HF. This peptide
was available from a previous study (12) on the total chemical
synthesis of kalata B1, where the linear peptide was synthe-
sized with a free C terminus to allow cyclization. The N termini
of the permutants were unprotected and, hence, positively
charged.
The permutants of kalata B1 were assembled using manual
solid phase peptide synthesis and subsequently purified using
RP-HPLC before oxidation. The oxidation conditions were cho-
sen based on our previous studies (12) on the synthesis of
kalata B1, which revealed that cyclic, reduced kalata B1 folds
very efficiently in 0.1 M ammonium bicarbonate (pH 8), 1 mM
reduced glutathione in 50% (v/v) 2-propanol at room tempera-
ture. Applying these oxidation conditions to the folding of the
kalata B1 permutants enabled a comparison of the efficiency of
folding and allowed the effect of opening the loops of the parent
circular molecule to be assessed.
The HPLC traces used to monitor the folding reactions of the
acyclic permutants of kalata B1 are given in Fig. 3. We have
shown previously (12) that correctly folded kalata B1 elutes
significantly later than the reduced circular peptide because of
a large patch of surface-exposed hydrophobic residues in the
native conformation (10). The RP-HPLC trace for folding of the
circular form is, thus, included in Fig. 3 for comparison. Inspec-
tion of the traces for the new acyclic permutants shows that in
all but two cases a sharp, late-eluting peak is observed together
with a set of broader, earlier-eluting peaks. It appears likely
that the sharp peaks (marked N* in Fig. 3) correspond to
native-like folds and that the broader peaks correspond to
misfolded derivatives. This interpretation is consistent with
our earlier study (12) of kalata B1(8–7), which we used as a
precursor in the synthesis of circular kalata B1. There we noted
that linear kalata B1(8–7) displays similar HPLC properties to
the cyclic peptide, in that the reduced form elutes much earlier
than the correctly folded form, which yields a sharp, late-
eluting peak. The misfolded forms had broad peaks that were
poorly resolved and were much more hydrophilic than the
correctly folded form, as shown by their shorter retention
times.
The absence of late-eluting peaks for des-3-kalata B1 (1) and
TABLE I
Acyclic permutants of kalata B1
The native sequence is backbone-cyclized. The N and C termini of the
acyclic permutants are in bold. The nomenclature chosen describes the
residues deleted, or in the case of the full length, non-cyclic permutants,
the residue numbers of the N and C termini are in parentheses. The
numbers in parentheses after the name of the permutant refer to the
loop that is perturbed, with des-(23–28)-kalata B1 and kalata B1(24–
23) designated 6a and 6b, respectively.
FIG. 2. A schematic representation
of the three-dimensional structure of
kalata B1 (middle of diagram) and
the six acyclic permutants produced
upon opening of the six loops be-
tween the cysteine residues. The num-
bers in parentheses represent the loops
that are opened.
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des-(16)-kalata B1 (4) suggests that correctly folded peptides
are not formed in these cases. In an attempt to find conditions
where des-(3)-kalata B1 and des-(16)-kalata B1 produce a sim-
ilar folding pattern to the other permutants and to the native
peptide, several conditions were varied, including the buffer,
temperature, length of oxidation, and presence of denaturants.
However, the HPLC traces from these reactions did not differ
significantly from those shown in Fig. 3. These results imply
the regions between Cys-1 and Cys-5, and Cys-15 and Cys-17,
which correspond to loops 1 and 4 (Table I), are structurally
very important. Opening the peptide chain in these loop seg-
ments produces a fundamental change in the ability of the
molecule to fold to a native-like conformation. By contrast, the
other four loops can be cut and still allow folding into the native
conformation.
NMR Spectroscopy—To further characterize the conforma-
tions of the folded forms associated with the late- eluting peaks,
they were purified by RP-HPLC and studied by 1H NMR spec-
troscopy. TOCSY and NOESY spectra were recorded for the
acyclic permutants 2, 3, 5, 6a, and 6b, and resonance assign-
ments were obtained using established techniques (31).
Chemical shifts are extremely sensitive to structural
changes and, thus, an analysis of the chemical shifts was first
used to compare the structures of the permutants. Fig. 4 shows
the differences in aH chemical shifts between the acyclic per-
mutants and the native peptide. For most residues, the permu-
tants have similar shifts to the native peptide, indicating that
the overall three-dimensional structure is retained. This con-
firms the finding from the HPLC data that it is possible to
produce correctly folded acyclic permutants.
In general, the largest chemical shift differences are near the
introduced termini, as might be expected because of the break-
age of a peptide bond and the introduction of new charges;
however, other differences also exist. The most significant are
in kalata B1(24–23), i.e. 6b, the permuted derivative where
loop 6 is opened. In this case the large chemical shift changes
over residues 23–29 relative to the native peptide reflect an
untethering of loop 6. The chemical shifts in this region of the
acyclic permutant are much closer to random coil values than
they are in the native peptide, consistent with local structuring
of this region in the native circular protein but disorder in the
open chain derivative. This conclusion is also consistent with
the HPLC retention time for this permutant, which is signifi-
cantly faster than for the native peptide despite having the
same amino acid composition and with chemical shift data for
the truncated permutant, 6a. Most of the residues in loop 6 are
removed in the truncated permutant, and the expected large
changes in chemical shifts occur at the new terminal residues,
23 and 29, but other residues are unaffected.
Putting aside these local conformational changes due to the
introduction of breaks in the circular protein backbone, the
very significant finding to emerge from the aH chemical shift
analysis is that the overall structures of the folded acyclic
permutants are very similar to that of the native circular
protein. Circularization is not essential for correct folding.
Changes in bH chemical shifts were also found to be ex-
tremely useful for comparing structures of the permutants,
particularly for Cys side-chain conformations. The chemical
shift separation of the two b-protons in each AMX spin system
in the permutants was measured, and the values were sub-
tracted from the corresponding shift separations in the native
peptide. The results are shown in Fig. 5, but before examining
these relative changes in bH shift separations, it is useful to
examine the base-line values in the native peptide. In kalata
B1 the bH chemical shift separations for individual AMX res-
idues range from 0.0 ppm (Asn-11, Ser-13, Trp-19) to 1.20 ppm
(Cys-15) and are typically 0.35 6 0.1 ppm for the other Cys
residues. In general, the larger the bH chemical shift separa-
tion for an individual methylene pair of protons, the more likely
that pair is located in a highly structured environment. A de-
crease in shift separation in a permutant relative to the native
peptide indicates a change to a more disordered environment.
Fig. 5 shows that most of the changes in shift separations are
indeed negative in sign, so that permutation does in general
lead to decreased order in side-chain environments. The effects
are very small for kalata B1(8–7) (2) and des-(19–20)-kalata
B1 (5), whose bH shift separations are within 0.2 ppm of the
native peptide, confirming that there are no significant struc-
tural changes associated with opening of loops 2 or 5. There are
more significant differences for des-(12–13)-kalata B1 (3), des-
(24–28)-kalata B1 (6a), and kalata B1(24–23) (6b), particu-
larly at Cys-15. Opening of loop 3 or 6 thus appears to have a
greater effect on disulfide bond geometry than does opening
loop 2 or 5. Interestingly, increased bH shift separations are
observed in most of the permutants for Cys-10 and Cys-22,
which make up the “penetrating” disulfide bond.
A range of additional structural data was also measured for
the various permutants, including the location of hydrogen
bonds, inferred from slow exchange amide data, long range aa
FIG. 3. HPLC traces of oxidation reactions on the synthetic
acyclic permutants of kalata B1. Linear reduced peptides were
oxidized in 50% 2-propanol, 1 mM reduced glutathione in 0.1 M ammo-
nium bicarbonate (pH 8). The reactions were conducted at room tem-
perature for 24 h. The correctly folded forms are labeled with N*.
Oxidation of cyclic, reduced peptide (N) is included in the diagram for
comparison.
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NOEs indicative of b-sheet, and 3JaHNH coupling constants
indicative of b-strands. A summary of the secondary structure
elements present in the permutants as deduced from these
data is given in Fig. 6. These are broadly consistent with the
chemical shift analysis and indicate that a significant degree of
native secondary structure is maintained in most of the acyclic
permutants. Des-(12–13)-kalata B1 (3) appears to be the least
structured of the folded forms, but even it contains many large
(.8.5 Hz) 3JaHNH coupling constants and a cross-sheet aa
NOE, consistent with significant maintenance of the sheet. The
sheet in this permutant appears to be subject to more breathing
motions than in the native peptide, however, as no slowly
exchanging amide protons were detected. In the other folded
permutants most of the native hydrogen bonds were maintained.
FIG. 4. aH chemical shift differ-
ences between the acyclic permu-
tants of kalata B1 and native kalata
B1. Only the four permutants that pro-
duced late-eluting peaks were analyzed.
The chemical shifts were measured from
TOCSY spectra recorded on a Bruker
ARX 500 MHz spectrometer at 298 K and
are referenced to internal DSS. Arrows
above the shifts represent the secondary
structure; the black arrows represent the
b-hairpin, and the white arrows represent
the distorted strand, which has a b-bulge
present.
FIG. 5. Differences in the separa-
tion of the two b protons in the AMX
spin systems in the acyclic permu-
tants of kalata relative to the shift
separation in native kalata B1. The
chemical shifts were measured from
TOCSY spectra recorded on a Bruker
ARX 500 MHz spectrometer at 298 K and
are referenced to internal DSS. The disul-
fide connectivities, based on the native
peptide, are shown at the bottom of the
figure to facilitate tracking of trends for
connected cysteine residues.
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The amide exchange rates for native kalata B1 and the
acyclic permutants are given in Table II. Des-(12–13)-kalata B1
(3) is not included as the amide signals were exchanged within
25 min of dissolving in 2H2O. Des-(19–20)-kalata B1 (5), des-
(24–28)-kalata B1 (6a), and kalata B1(24–23) (6b) in general
have exchange rates higher than that observed for the native
peptide, suggesting that the overall stability has been de-
creased. In contrast, kalata B1(8–7) (2) has exchange rates
closer to those observed for the native peptide, which implies
that opening the peptide backbone in loop 2 does not signifi-
cantly affect the stability.
In summary, the combined NMR and HPLC data showed
that only two of the six topologically distinct acyclic permu-
tants did not fold, and these were associated with cuts to loops
1 or 4. Acyclic permutants with cuts to the other four loops
folded similarly to the native circular protein.
Hemolytic Activity—The cyclotides have a diverse range of
biological activities, but their natural function within plants is
not yet known. Membrane disruption is potentially a common
feature of these various activities, and so it was convenient to
use a hemolytic assay to monitor the biological effects of acyclic
permutation. Kalata B1 has previously been shown to have
hemolytic activity (12, 13), and this was confirmed in the cur-
rent study, where 50% hemolysis occurs on incubation of eryth-
rocytes with 50 mM kalata B1. Recent studies have shown that
factors such as high amphipathicity, high hydrophobicity, and
high helicity correlate with high hemolytic activity (32). Thus,
it is not surprising that the level of hemolytic activity observed
for the non-helical kalata B1 is rather mild and less than that
for highly helical peptides such as melittin (,1 mM for 50%
hemolysis) (33). However, despite the ready detection of activ-
ity for the parent kalata molecule, no lysis was observed for the
acyclic permutants at concentrations of up to ;60 mM. Thus it
appears that circularization of the backbone is not required for
correct folding but is required for hemolytic activity.
DISCUSSION
This examination of the in vitro folding of acyclic permutants
of the cyclotide peptide, kalata B1, has highlighted some im-
portant features required for folding. We have essentially
opened kalata B1 within each of the six loops spanning consec-
utive cysteine residues and have found a characteristic pattern
of folded forms upon oxidation of the cysteine residues as de-
termined by RP-HPLC and NMR spectroscopy. In general, the
folded forms elute significantly closer to the native material
and much later than misfolded forms. The misfolded forms also
yield broad HPLC peaks compared with the correctly folded
form. Several of the misfolded peaks were isolated and found by
mass spectrometry to contain three disulfide bonds; however,
the retention times were significantly different from the cor-
rectly folded form, indicating a different conformation. Sharp,
late-eluting peaks were observed for all but two of the acyclic
permutants and, based on analysis of aH and bH chemical
shifts, represent molecules in which the overall three-dimen-
sional structure and disulfide connectivity of the native circu-
lar peptide are retained. Thus, we have shown that it is possi-
ble to form the native structure in a range of linear analogues
with permuted termini.
The proportion of the late-eluting native peaks to misfolded
peaks varied significantly for the different permutants as did
the retention times of the native-folded permutants. Amino
acid composition had a significant effect on retention time,
particularly when the tryptophan residue was removed as seen
in Fig. 3 for des-(19–20)-kalata B1. However, retention time
also provided a good guide as to how similar a permutant was
to the native conformation. For example, Fig. 3 shows that
kalata B1(24–23) elutes earlier than the native peptide despite
containing the entire amino acid sequence, and thus, the dif-
ference in retention time must be accounted for by a conforma-
tional change. Structural studies showed that this is associated
with disorder in the newly opened loop 6 in this permutant.
The major secondary structure element of kalata B1 is a
FIG. 6. Summary of experimental NMR data used to determine
the b-sheet regions of the acyclic permutants of kalata B1. The
hydrogen bonds, deduced from slow exchange data, are represented as
dashed lines, with the narrow end corresponding to the hydrogen bond
donor and the wider end corresponding to the hydrogen bond acceptor.
Observed aH-aH NOEs across the sheet are shown as double-headed
arrows, and residues with large (.8.5 Hz) 3JaHNH coupling constants
are highlighted with asterisks.
TABLE II
Experimental amide exchange rates (kex, min
21) for native kalata B1
and the acyclic permutants
Des-(12–13)-kalata B1 was not included because all amide signals
had exchanged within 25 min of dissolving in 2H2O. A dash indicates
the residue was not present.
Residue
kex
Native
kalata B1
Kalata
B1-(8–7)
Des-(19–20)-
kalata B1
Des-(24–28)-
kalata B1
Kalata
B1(24–23)
1023 min21
Cys-5 2.7 8.9 .40 .40 .40
Cys-15 1.1 1.7 1.6 31 8.6
Thr-16 2.3 1.7 27 .40 .40
Ser-18 0.37 7.7 .40 38 18
Val-21 1.6 1.3 a 6.0 5.3
Cys-22 0.83 1.7 .40 10 9.0
Thr-23 0.63 1.5 7.1 13 8.2
Arg-24 3.3 4.8 17 — a
Leu-27 2.9 3.9 6.6 — .40
Val-29 1.3 1.7 8.3 a .40
a An N-terminal residue.
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distorted triple-stranded b-sheet, which is defined primarily by
NOEs between a protons across the strands of the sheet, and
hydrogen bonds, which are inferred from slow exchange data.
Large 3JaHNH coupling constants, which are also indicative of
extended structures, are also present in the sheet region. Anal-
ysis of NOESY spectra, 2H2O exchange data, and
3JaHNH cou-
pling constants for the acyclic permutants allowed the extent to
which this b-sheet structure is retained to be determined (Fig.
6).
When loops 2, 5, and 6 are cut, a significant amount of the
b-sheet structure is retained. Interestingly, the b-hairpin of
kalata B1 remains intact when either loop 2 or loop 6 is opened
and is partially formed when loop 5 is opened, despite the turn
residues being deleted in the latter case. Studies on b-hairpin
formation have generally suggested that the turn is formed
first, followed by the remaining native hydrogen bonds. How-
ever, a recent study suggested that the sheet may propagate
outwards following formation of a hydrophobic cluster (34). The
results from the present study appear to support the latter
conclusion, as des-(19–20)-kalata B1 has the turn residues of
the b-hairpin removed but still partially forms the b-hairpin.
As with loops 2, 5, and 6, cutting loop 3 also does not inhibit
formation of a folded conformation according to the HPLC data
and the aH chemical shifts for des-(12–13)-kalata B1, which
suggest it has substantially retained native structure. However
this acyclic permutant appears not to be stabilized by hydrogen
bonds, as is evident from a lack of slowly exchanging amide
protons. Although loop 3 is not directly involved in the dis-
torted triple-stranded b-sheet, it appears to have a significant
role in stabilizing the structure through hydrogen bonds.
Analysis of bH shift separations for the acyclic permutants
provided valuable structural information, particularly for the
cysteine residues, which make up more than half the AMX
systems in these molecules. These data confirmed the conclu-
sions from the aH shift analysis that the acyclic permutants
with loops 2, 3, 5, and 6 removed largely retained native struc-
ture but provided additional details on differences associated
with cutting loops 2 or 5 relative to loops 3 or 6, monitored
mainly by perturbations to Cys-15 shift separations. It appears
that the opening of loops 3 or 6 produces more disorder in the
adjacent disulfide bond (Cys-1–Cys-15, labeled as CysI-CysIV
in Fig. 2) than does the opening of loops 2 or 5, with loop 3 being
most critical. Loops 2 (VGGT) and 5 (SWPV) are characterized
by two b turns, which are held rigidly together, one below the
other, by the adjacent cystine knot core of the molecule. This
appears to be the most well defined part of the framework, but
its stability appears to be driven by the knot rather than the
turns themselves. Removal of these turns causes minimal dis-
ruption to the structures.
In most cases there was decreased chemical shift separation
of the b protons in the permutants relative to the native pep-
tide, implying more disorder in the permutants; however;
Cys-10 and Cys-22, which together form the penetrating disul-
fide bond of the cystine knot, consistently showed a greater
chemical shift separation in the permutants relative to the
native peptide. This may reflect strain associated with this
bond in the native circular peptide that is relieved in the
permutants.
In contrast to the case for loops 2, 3, 5, and 6, when either
loop 1 or 4 was opened, the characteristic native folding pattern
was not observed on RP-HPLC. This result suggests that the
native-like structure was not formed in these two permutants,
and it appears likely that the correct disulfide connectivities
were not formed. Loops 1 and 4, thus, have a significant role in
protein folding. The fundamental difference in folding between
acyclic permutants that involve a cut in loops 2, 3, 5, or 6 and
those that involve a cut in loops 1 or 4 appears to be related to
the integrity of the cystine knot core of these molecules. From
Figs. 1 and 2 it is clear that cutting of either loops 1 or 4 results
in opening of the embedded ring in the structures formed by
disulfide bonds Cys-1–Cys-15 (I-IV in Fig. 2) and Cys-5–Cys-17
(II-V in Fig. 2) and their connecting backbone segments. The
topology diagrams in Fig. 7 show this more clearly. The two
outer, or ring-forming, disulfide bonds are represented by black
lines, with a shaded line for the penetrating disulfide bond.
When the connection between the outer disulfide bonds is in-
terrupted by the termini of the molecule, as occurs in des-(3)-
kalata B1 (1) and des-(16)-kalata B1 (4), these molecules do not
fold. In contrast, when the outer disulfide bonds can be con-
nected to form a ring, the permutants fold into the native
conformation, i.e. the embedded ring must be intact to allow
folding into the native conformation. Furthermore, formation
of the complete set of b-sheet interactions (i.e. aa NOEs and
hydrogen bonds) does not appear to be critical in folding of
kalata B1 into a native-like conformation.
The importance of loops 1 and 4, which make up the connect-
ing segments of the embedded ring, is reflected in their high
level of conservation throughout the cyclotide family of macro-
cyclic peptides (3). Loop 1 (CGE(T/S)C) is conserved throughout
the cyclotides. Similarly, loop 4 (C(T/S)C) is also conserved not
only in terms of size but also content. The remaining loops in
the peptides generally have little homology across the cyclotide
family; however, there are some highly conserved sequences
FIG. 7. A representation of the cystine knot motif in the per-
mutants of kalata B1. The cysteine residues are numbered, and the
spacings between each of the cysteine residues are indicated with
dashes. The disulfide bonds are represented as lines, and the core of the
cystine knot is highlighted in thick lines. The shaded line represents the
disulfide bond which “threads” through the other two disulfide bonds.
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within subsets of these peptides (3, 12). The relative lack of
sequence conservation in the remaining loops may reflect a
decreased structural importance of these regions, but variabil-
ity may have evolved associated with various biological activi-
ties of different members of the cyclotide family.
The cyclotide peptides exhibit a diverse range of biological
activities that originally appeared to be unrelated, ranging
from uterotonic to anti-human immunodeficiency virus. How-
ever, the hemolytic and anti-microbial activity displayed by
several of the peptides (11–13) may give an insight into a
common mechanism of action. Membrane disruption is a fea-
ture of many hemolytic or antimicrobial compounds and may
well explain the other activities of the cyclotides. It was of
particular interest in the current study to determine whether a
circular backbone per se was essential for activity of this family
of fascinating proteins.
The acyclic permutants of kalata B1 that folded into the
native-like conformation provided an opportunity to assess the
effect of opening the circular backbone in topologically different
regions on hemolytic activity. Despite having retained the over-
all three-dimensional structure of the native peptide, as shown
by NMR analysis, none of the acyclic permutants was active.
Consequently, loss of activity cannot be localized to perturba-
tion of a particular region of the molecule and circularization
does indeed appear to be critical. Amide exchange measure-
ments were undertaken to see if flexibility or stability is af-
fected by circularization.
In general, exchange rates of amide protons can provide
valuable information on protein stability, folding, and dynam-
ics (35). In the current study we observed an increase in the
amide exchange rates in most of the acyclic permutants, sug-
gesting that they are generally more flexible or less stable than
the native peptide. Thus, the lack of activity of the permutants
in the hemolytic assay may well be a result of increased flexi-
bility. However, other factors must also contribute in individ-
ual cases, because the kalata B1(8–7) permutant has similar
amide exchange rates to the native peptide but was inactive in
the hemolytic assay. In general, though, circularization does
appear to increase the stability of the cyclotides.
A recent study on the anti-microbial activity of several mac-
rocyclic peptides from the cyclotide family suggested that their
positive charges may be important and that the initial inter-
actions with the microbial surface may be electrostatic (13).
This is consistent with hemolytic activity data, as the circulins,
which have a higher net positive charge than kalata B1, are
more active than kalata B1. Anti-microbial studies also re-
vealed a marked decrease in activity of kalata B1 when its
single Arg residue was modified (13). However, the Arg residue
of kalata B1 is retained in four of the acyclic permutants that
appear to fold into the native-like conformation but are inactive
in the hemolytic assay. This suggests that the presence of the
Arg residue alone in a native-folded framework does not confer
activity.
In summary, we have introduced the concept of acyclic per-
mutation of a circular protein. Using a prototypic member of
the cyclotide family, we have shown that cutting the backbone
in such as way as to open an embedded ring within the struc-
ture disrupts the ability of the molecule to fold. On the other
hand cutting the backbone in four of six topologically distinct
ways that do not disrupt the cystine knot core does not inhibit
folding into native conformations. The study shows that integ-
rity of the core cystine knot is essential to folding and paves the
way for further exploitation of the cyclic cystine knot as a
template in a diverse range of molecular design applications.
Acknowledgment—We thank Dianne Alewood for some preliminary
syntheses.
REFERENCES
1. Boissinot, M., Karnas, S., Lepock, J. R., Cabelli, D. E., Tainer, J. A., Getzoff,
E. D., and Hallewell, R. A. (1997) EMBO J. 16, 2171–2178
2. Viguera, A. R., Serrano, L., and Wilmanns, M. (1996) Nat. Struct. Biol. 3,
874–880
3. Craik, D. J., Daly, N. L., Bond, T., and Waine, C. (1999) J. Mol. Biol. 294,
1327–1336
4. Gran, L. (1970) Medd. Nor. Farm. Selsk. 12, 173–180
5. Gran, L. (1973) Lloydia (Cinci.) 36, 174–178
6. Gran, L. (1973) Lloydia (Cinci.) 36, 207–208
7. Gran, L. (1973) Acta Pharmacol. Toxicol. 33, 400–408
8. Gustafson, K. R., Sowder II, R. C., Henderson, L. E., Parsons, I. C., Kashman,
Y., Cardellina, J. H., II, McMahon, J. B., Buckheit, R. W., Jr., Pannell, L. K.,
and Boyd, M. R. (1994) J. Am. Chem. Soc. 116, 9337–9338
9. Witherup, K. M., Bogusky, M. J., Anderson, P. S., Ramjit, H., Ransom, R. W.,
Wood, T., and Sardana, M. (1994) J. Nat. Prod. (Lloydia) 57, 1619–1625
10. Saether, O., Craik, D. J., Campbell, I. D., Sletten, K., Juul, J., and Norman,
D. G. (1995) Biochemistry 34, 4147–4158
11. Scho¨pke, T., Hasan Agha, M. I., Kraft, R., Otto, A., and Hiller, K. (1993) Sci.
Pharm. 61, 145–153
12. Daly, N. L., Love, S., Alewood, P. F., and Craik, D. J. (1999) Biochemistry 38,
10606–10614
13. Tam, J. P., Lu, Y. A., Yang, J. L., and Chiu, K. W. (1999) Proc. Natl. Acad. Sci.
U. S. A. 96, 8913–8918
14. Claeson, P., Go¨ransson, U., Johansson, S., Luijendijk, T., and Bohlin, L. (1998)
J. Nat. Prod. (Lloydia) 61, 77–81
15. Go¨ransson, U., Luijendijk, T., Johansson, S., Bohlin, L., and Claeson, P. (1999)
J. Nat. Prod. (Lloydia) 62, 283–286
16. Daly, N. L., Koltay, A., Gustafson, K., R., Boyd, M. R., Casas-Finet, J. R., and
Craik, D. J. (1999) J. Mol. Biol. 285, 333–345
17. Derua, R., Gustafson, K. R., and Pannell, L. K. (1996) Biochem. Biophys. Res.
Commun. 228, 632–638
18. Pallaghy, P. K., Nielsen, K. J., Craik, D. J., and Norton, R. S. (1994) Protein
Sci. 3, 1833–1839
19. McDonald, N. Q., and Hendrickson, W. A. (1993) Cell 73, 421–424
20. Daquinag, A. C., Sato, T., Koda, H., Takao, T., Fukuda, M., Shimonishi, Y., and
Tsukamoto, T. (1999) Biochemistry 38, 2179–2188
21. Tamaoki, H., Miura, R., Kusunoki, M., Kyogoku, Y., Kobayashi, Y., and
Moroder, L. (1998) Protein Eng. 11, 649–659
22. Schno¨lzer, M., Alewood, P., Jones, A., Alewood, D., and Kent, S. B. H. (1992)
Int. J. Pept. Protein Res. 40, 180–193
23. Marion, D., and Wu¨thrich, K. (1983) Biochem. Biophys. Res. Commun. 113,
967–974
24. Rance, M., Sørensen, O. W., Bodenhausen, G., Wagner, G., Ernst, R. R., and
Wu¨thrich, K. (1983) Biochem. Biophys. Res. Commun. 117, 479–485
25. Braunschweiler, L., and Ernst, R. R. (1983) J. Magn. Reson. 53, 521–528
26. Bax, A., and Davis, D. G. (1985) J. Magn. Reson. 65, 355–360
27. Jeener, J., Meier, B. H., Bachmann, P., and Ernst, R. R. (1979) J. Chem. Phys.
71, 4546–4553
28. Piotto, M., Saudek, V., and Sklenar, V. (1992) J. Biomol. NMR 2, 661–665
29. Chakshusmathi, G., Ratnaparkhi, G. S., Madhu, P. K., and Varadarajan, R.
(1999) Proc. Natl. Acad. Sci. U. S. A. 96, 7899–7904
30. Terras, F. R. G., Schoofs, H. M. E., De Bolle, M. F. C., Van Leuven, F., Rees,
S. B., Vanderleyden, J., Cammue, B. P. A., and Broekaert, W. F. (1992)
J. Biol. Chem. 267, 15301–15309
31. Wu¨thrich, K. (1986) NMR of Proteins and Nucleic Acids, John Wiley & Sons,
Inc., New York
32. Kondejewski, L. H., Jelokhani-Niaraki, M., Farmer, S. W., Lix, B., Kay, C. M.,
Sykes, B. D., Hancock, R. E., and Hodges, R. S. (1999) J. Biol. Chem. 274,
13181–13192
33. Oren, Z., and Shai, Y. (1997) Biochemistry 36, 1826–1835
34. Dinner, A. R., Lazaridis, T., and Karplus, M. (1999) Proc. Natl. Acad. Sci.
U. S. A. 96, 9068–9073
35. Englander, S. W., Sosnick, T. R., Englander, J. J., and Mayne, L. (1996) Curr.
Opin. Struct. Biol. 6, 18–23
Acyclic Permutants of Kalata B1 19075
 at UQ Library on October 25, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Norelle L. Daly and David J. Craik
THE MACROCYCLIC POLYPEPTIDE KALATA B1
-SHEET FORMATION INβCHARACTERIZATION OF CYSTINE KNOT AND 
Acyclic Permutants of Naturally Occurring Cyclic Proteins:
doi: 10.1074/jbc.M000450200 originally published online March 27, 2000
2000, 275:19068-19075.J. Biol. Chem. 
  
 10.1074/jbc.M000450200Access the most updated version of this article at doi: 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
  
 http://www.jbc.org/content/275/25/19068.full.html#ref-list-1
This article cites 0 references, 0 of which can be accessed free at
 at UQ Library on October 25, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
